1 / 3
google
Article details
- Package size
- 15
- Selling units
- 15
- Measure
- g
- Galenic form
- Crème
- Galenic group
- Salben
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | WIZUS |
|
(N/A)
|
8.8 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
40.0 MG | Substance | HBESI |
|
(N/A)
|
40.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
10.0 MG | Substance | HBESI |
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 51307
- Drug name
- Lamisil, Crème
- Galenic form
- CREM
- ATC Code
- D01AE15
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 18/09/1991
- Authorization expiration date
- 31/12/9999
- IT Number
- 10.09.4.
- Domain
- Human medicine
Package details
- Description (FR)
- LAMISIL crème 1 % tb 15 g
- Description (DE)
- LAMISIL Creme 1 % Tb 15 g
- Market launch
- 18/09/1991
- Narcotic (BTM)
- No